Please Wait.....
Report
Middle East and Africa Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Carmine, Anthocyanins, Caramel, Curcumin, Annatto, Carotenoids, Chlorophyll, and Others), Form (Liquid & Gel and Powder), and Application (Bakery and Confectionery, Dairy and Frozen Desserts, Beverages, Sauces; Dressings; and Condiments, RTC and RTE Products, Meat; Poultry and Seafood, and Others)
Market Report I 2022-12-19 I 171 Pages I The Insight Partners
The intravenous immunoglobulin market in the MEA is expected to grow from US$ 497.97 million in 2022 to US$ 711.99 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
Rising Prevalence of Immunodeficiency Diseases
Intravenous immunoglobulin (IVIG) is used to treat patients suffering from primary and secondary immunodeficiencies and autoimmune disorders. IVIG is a standard therapy to treat most of the primary immunodeficiencies (PID). The rare genetic diseases can be chronic, weakening, and expensive to treat. Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by abnormally low levels of platelets; a situation referred to as thrombocytopenia. As per the Rare Diseases Organization, around 200,000 ITP cases are recorded across the region annually. Thus, increasing prevalence of immunodeficiency diseases drives the growth of the intravenous immunoglobulin market.
Market Overview
The Middle East & Africa intravenous immunoglobulin market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East & Africa. Saudi Arabia was this region's largest intravenous immunoglobulin market in 2021. The Middle East & Africa intravenous immunoglobulin market is anticipated to grow at a CAGR of 6.1% during the forecast period; this growth can be attributed to the increasing government support for healthcare and the rising awareness regarding IgRT. The increasing prevalence of GBS and infectious diseases drives the intravenous immunoglobulin market in Saudi Arabia. According to the article, "Application of intravenous immunoglobulin (IVIg) to modulate inflammation in critical COVID-19," published in the National Library of Medicine (NLM) in 2021, administration of IVIg within a specific dosage was extremely beneficial toward reducing mortality and perhaps even the length of hospitalization of patients exhibiting severe COVID-19 symptoms.
MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
MEA Intravenous Immunoglobulin Market Segmentation
The MEA intravenous immunoglobulin market is segmented into type, application, distribution channel, end user, and country. Based on type, the market is segmented into IgG, IgM, IgA, IgE, and IgD. The IgG segment registered the largest market share in 2022.
Based on application, the MEA intravenous immunoglobulin market is segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency diseases, myasthenia gravis (MG), multifocal motor neuropathy (MMN), idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency (SDA), Guillain-Barre syndrome (GBS), and others. The immunodeficiency diseases segment registered the largest market share in 2022.
Based on distribution channel, the MEA intravenous immunoglobulin market is segmented into hospital pharmacy, retail pharmacy, and others. The hospital pharmacy segment registered the largest market share in 2022.
Based on end user, the MEA intravenous immunoglobulin market is segmented into hospitals, specialty clinics, and others. The hospitals segment registered the largest market share in 2022.
Based on country, the market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of MEA. Saudi Arabia dominated the market in 2022.
ADMA Biologics, Inc.; Bio Products Laboratory Ltd.; CSL Behring (CSL Limited); Grifols, S.A.; Kedrion S.p.A; Octapharma AG; Pfizer Inc.; Prothya Biosolutions B.V.; Shanghai RAAS; and Takeda Pharmaceutical Company Limited are among the leading companies operating in the intravenous immunoglobulin market in the region.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Intravenous Immunoglobulin Market - By Type
1.3.2 MEA Intravenous Immunoglobulin Market - By Application
1.3.3 MEA Intravenous Immunoglobulin Market - By Distribution Channel
1.3.4 MEA Intravenous Immunoglobulin Market - By End User
1.3.5 MEA Intravenous Immunoglobulin Market - By Country
2. MEA Intravenous Immunoglobulin Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Intravenous Immunoglobulin Market - Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion
5. MEA Intravenous Immunoglobulin Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Immunodeficiency Diseases
5.1.2 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 Adverse Effects of Immunoglobulin Therapy
5.3 Future Trends
5.3.1 Strong Pipeline Candidates for IVIG
5.4 Impact Analysis
6. Intravenous Immunoglobulin Market- MEA Analysis
6.1 MEA Intravenous Immunoglobulin Market Revenue Forecast and Analysis
7. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028- by Type
7.1 Overview
7.2 MEA Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)
7.3 IgG
7.3.1 Overview
7.3.2 IgG Revenue and Forecast to 2028 (US$ Million)
7.4 IgM
7.4.1 Overview
7.4.2 IgM - Revenue and Forecast to 2028 (US$ Million)
7.5 IgA
7.5.1 Overview
7.5.2 IgA - Revenue and Forecast to 2028 (US$ Million)
7.6 IgE
7.6.1 Overview
7.6.2 IgE - Revenue and Forecast to 2028 (US$ Million)
7.7 IgD
7.7.1 Overview
7.7.2 IgD - Revenue and Forecast to 2028 (US$ Million)
8. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Application
8.1 Overview
8.2 MEA Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)
8.3 Hypogammaglobulinemia
8.3.1 Overview
8.3.2 Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Chronic Inflammatory Demyelinating Polyneuropathy
8.4.1 Overview
8.4.2 Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Myasthenia Gravis
8.6.1 Overview
8.6.2 Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)
8.7 Multifocal Motor Neuropathy
8.7.1 Overview
8.7.2 Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Idiopathic Thrombocytopenic Purpura
8.8.1 Overview
8.8.2 Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)
8.9 Inflammatory Myopathies
8.9.1 Overview
8.9.2 Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)
8.10 Specific Antibody Deficiency
8.10.1 Overview
8.10.2 Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)
8.11 Guillain-Barre Syndrome
8.11.1 Overview
8.11.2 Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Distribution Channel
9.1 Overview
9.2 MEA Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by End User
10.1 Overview
10.2 MEA Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Specialty Clinics
10.4.1 Overview
10.4.2 Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)
11. MEA Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 - Country Analysis
11.1 Overview
11.1.1 Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
11.1.1.1 Saudi Arabia: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.1.1 Overview
11.1.1.1.2 Saudi Arabia Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.1.4 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.1.5 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
11.1.1.1.6 Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.1.1.2 South Africa: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.2.1 Overview
11.1.1.2.2 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.2.4 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.2.5 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.1.1.2.6 South Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.1.1.3 UAE: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.3.1 Overview
11.1.1.3.2 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.3.4 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.3.5 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.1.1.3.6 UAE: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
11.1.1.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (USD Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of the Middle East and Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
11.1.1.4.4 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Application (US$ Million)
11.1.1.4.5 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By Distribution Channel (US$ Million)
11.1.1.4.6 Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast To 2028, By End User (US$ Million)
12. MEA Intravenous Immunoglobulin Market-Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Grifols, S.A.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 ADMA Biologics, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio Products Laboratory Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Shanghai RAAS
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Octapharma AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kedrion S.p.A
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CSL Behring (CSL Limited)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Prothya Biosolutions B.V.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms in Intravenous Immunoglobulin Market
LIST OF TABLES
Table 1. MEA Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 3. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 4. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 5. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 6. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 7. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 8. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 9. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 10. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 11. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 12. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 13. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 14. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Type (US$ Million)
Table 15. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 16. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By Distribution Channel (US$ Million)
Table 17. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market
Table 19. Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market
Table 20. Glossary of Terms in Intravenous Immunoglobulin Market
LIST OF FIGURES
Figure 1. MEA Intravenous Immunoglobulin Market Segmentation
Figure 2. MEA Intravenous Immunoglobulin Market Segmentation, By Country
Figure 3. MEA Intravenous Immunoglobulin Market Overview
Figure 4. MEA Intravenous Immunoglobulin Market, by Type
Figure 5. MEA Intravenous Immunoglobulin Market, by Country
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Impact Analysis
Figure 8. MEA Intravenous Immunoglobulin Market- Revenue Forecast and Analysis - 2020 - 2028
Figure 9. MEA Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)
Figure 10. MEA IgG Revenue and Forecasts to 2028 (US$ Million)
Figure 11. MEA IgM - Revenue and Forecasts to 2028 (US$ Million)
Figure 12. MEA IgA - Revenue and Forecasts to 2028 (US$ Million)
Figure 13. MEA IgE - Revenue and Forecasts to 2028 (US$ Million)
Figure 14. MEA IgD - Revenue and Forecasts to 2028 (US$ Million)
Figure 15. MEA Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)
Figure 16. MEA Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. MEA Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. MEA Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. MEA Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. MEA Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. MEA Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. MEA Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. MEA Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. MEA Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. MEA Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)
Figure 27. MEA Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. MEA Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. MEA Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. MEA Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)
Figure 31. MEA Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 32. MEA Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 33. MEA Others- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 34. Middle East & Africa Intravenous Immunoglobulin Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 35. Middle East & Africa Intravenous Immunoglobulin Market Revenue and Forecast to 2028, by Country (%)
Figure 36. Saudi Arabia: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. South Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. UAE: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Rest of the Middle East and Africa: Intravenous Immunoglobulin Market Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security